ArticleMediterranean journal of rheumatology2021

Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?

Ciro ManzoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.